Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Biology Laboratory, |
RCV001281281 | SCV001425010 | likely pathogenic | Autosomal dominant Alport syndrome | 2020-02-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001316984 | SCV001507626 | uncertain significance | not provided | 2021-08-13 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine with valine at codon 1666 of the COL4A3 protein (p.Met1666Val). The methionine residue is moderately conserved and there is a small physicochemical difference between methionine and valine. This variant is present in population databases (rs759583948, ExAC 0.02%). This missense change has been observed in individual(s) with COL4A3-related conditions (PMID: 33532864). ClinVar contains an entry for this variant (Variation ID: 974509). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001316984 | SCV005390594 | uncertain significance | not provided | 2024-03-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 33532864) |
Natera, |
RCV001836251 | SCV002076444 | uncertain significance | Alport syndrome | 2021-03-02 | no assertion criteria provided | clinical testing |